Human anti-IL-23 antibodies, compositions, methods and uses
First Claim
Patent Images
1. An isolated IL-23p19 antibody, comprising a light chain variable region and a heavy chain variable region, said light chain variable region comprising:
- a complementarity determining region light chain 1 (CDRL1) amino acid sequence of SEQ ID NO;
50;
a CDRL2 amino acid sequence of SEQ ID NO;
56; and
a CDRL3 amino acid sequence of SEQ ID NO;
73,said heavy chain variable region comprising;
a complementarity determining region heavy chain 1 (CDRH1) amino acid sequence of SEQ ID NO;
5;
a CDRH2 amino acid sequence of SEQ ID NO;
28; and
a CDRH3 amino acid sequence of SEQ ID NO;
44.
0 Assignments
0 Petitions
Accused Products
Abstract
A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
-
Citations
9 Claims
-
1. An isolated IL-23p19 antibody, comprising a light chain variable region and a heavy chain variable region, said light chain variable region comprising:
-
a complementarity determining region light chain 1 (CDRL1) amino acid sequence of SEQ ID NO;
50;a CDRL2 amino acid sequence of SEQ ID NO;
56; anda CDRL3 amino acid sequence of SEQ ID NO;
73,said heavy chain variable region comprising; a complementarity determining region heavy chain 1 (CDRH1) amino acid sequence of SEQ ID NO;
5;a CDRH2 amino acid sequence of SEQ ID NO;
28; anda CDRH3 amino acid sequence of SEQ ID NO;
44. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
Specification